Application of a multi-genotyping detection composition
By using a multi-genotyping detection composition in genotyping detection, combined with PCR and melting curve detection, the high cost and low efficiency problems of multi-genotyping and SNP detection in the prior art are solved, and high specificity and High throughput detection effect.
Patent Information
- Application Number
- CN202411237821.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-05
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-09-05
AI Technical Summary
Existing genotyping methods have problems of high cost, low efficiency and insufficient specificity in multi-genotyping and SNP detection, especially in the same tube, multi-genotyping detection or multi-mutation detection at the same SNP site. When , super multiple detection cannot be achieved.
Using a multigenotyping detection composition, including a universal quenching probe, specific amplification primer and universal signal probe, multigenotyping detection is achieved through the PCR reaction system, and using universal probes and specific amplification primers The combination of melting curve detection improves detection efficiency and sensitivity.
Achieve high specific, low-cost multi-genotyping detection, which can detect multiple genes in a single reaction, improve detection efficiency and sensitivity, and expand the detection range. It is suitable for genotyping, safe medication, tumor mutations and pathogens. Microbial drug resistance monitoring and other fields.
Smart Images

Figure CN118755808B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of gene detection, and in particular to an application of a multi-gene typing detection composition. Background Art
[0002] Polymerase chain reaction (PCR) technology is an indispensable detection tool in genetic testing, including genotyping detection and accurate quantification of target genes in samples. Based on the common PCR technology, by introducing fluorescent dyes or fluorescent probes for real-time fluorescence quantitative PCR, multiple targets can be detected with high specificity in the reaction. However, fluorescent group labeling increases the cost of analysis, and the increase in cost is proportional to the increase in the number of detection targets. Therefore, a highly specific and low-cost qPCR detection system is urgently needed.
[0003] Currently, the methods for genotyping detection based on PCR mainly include the probe method and dye-based high-resolution melting curve technology.
[0004] Probe method: Whether it is the TaqMan hydrolysis probe or the molecular beacon method, different fluorescent labeled probes need to be designed for each genotype or each mutation site of the target gene for detection. This is costly and difficult to design. For the detection of wild type and mutation of the same gene, simultaneous detection in the same tube cannot completely avoid cross-reactions, and false positive results are easily generated during detection. Moreover, the TaqMan hydrolysis probe method can only complete 4-5 typing tests for 1-2 genes in the same tube, and the number of typing is limited under the detection conditions of existing instruments.
[0005] Dye-based high-resolution melting curve technology: by adding double-stranded DNA fluorescent dyes to the PCR reaction system, the luminescence intensity of the dye embedded in the DNA double strand is higher than that of the free dye, and the melting temperature of the amplified DNA fragments of different genotypes is characterized to achieve genotyping detection. This method does not require the design of fluorescently labeled specific probes, is less restricted by mutation types, and has the advantages of low detection cost and high detection sample throughput. However, for small Tm value changes caused by single-point mutations, or even fragments with temperatures less than 0.4°C such as transversion homozygous mutations, the performance of ordinary fluorescent PCR instruments cannot meet this temperature requirement, and a specific PCR instrument is required. In addition, factors such as ion concentration and ion type in different PCR reaction systems will also cause subtle changes in Tm values. Errors caused by sample purity and the addition process will cause defects such as confusion of fluorescent signals, drift of melting curve peaks, and insufficient specificity.
[0006] KBiosciences in the UK has developed a genotyping technology for single nucleotide polymorphism (SNP) detection, competitive allele specific PCR (KASP), which uses three primers and four probes to complete target sequence PCR amplification and genotyping detection. Two primers with typing adapters and one universal primer achieve specific amplification of the target sequence and introduce probe sequences. The two typing probes and two complementary quenching probes dissociate and release fluorescent signals to characterize different SNP types as the reaction proceeds. KASP uses universal typing probes to reduce the cost of reagents and the difficulty of probe design and development, but this method still has technical defects for multi-genotyping detection in the same tube or for more than two mutation detections at the same SNP site, and cannot achieve ultra-multiple detection.
[0007] Therefore, in the application of multi-gene typing and SNP detection, a highly specific PCR detection method that is compatible with ultra-multiplex and high-throughput is needed. Summary of the invention
[0008] The purpose of the present invention is to provide an application of a multi-genotyping detection composition. The present invention mainly uses a universal probe to simultaneously perform typing detection on different genotypes in the same reaction tube, thereby improving detection efficiency, reducing reagent costs, and expanding the detection range.
[0009] In order to solve the above technical problems, the technical solution adopted by the present invention is:
[0010] An application of a multi-genotyping detection composition, wherein the multi-genotyping detection composition is applied to a PCR reaction system, wherein the multi-genotyping detection composition comprises a universal quenching probe, a plurality of specific amplification primers and a plurality of universal signal probes,
[0011] in,
[0012] The universal quenching probe and universal signaling probe are oligonucleotide chains that do not pair with the gene sequence of any known species to undergo an amplification reaction;
[0013] The 5' end of the universal signal probe is respectively labeled with different fluorescent signal groups, and the fluorescent signal of each fluorescent signal group can be quenched by the quenching group of the quenching probe;
[0014] The 5' end of the universal quenching probe is labeled with any one of MGB, BHQ1, BHQ2, BHQ3, and Dabcyl, a modification group that can quench the fluorescent signal labeled by the signal probe;
[0015] The specific amplification primer is a structure that uses a universal signal probe sequence and a universal quenching probe sequence combined with a specific target sequence as a specific amplification primer.
[0016] Specifically, it includes a specific amplification primer upstream primer and a specific amplification primer downstream primer. The specific amplification primer upstream primer is composed of three oligonucleotide sequence structures, the 5' end is a probe sequence region, the 3' end is an amplification sequence region specific to each genotype, and the 5' end and the 3' end are bridge bases; the specific amplification primer downstream primer is composed of three oligonucleotide sequence structures, the 5' end is a probe sequence, the 3' end is an amplification downstream primer specific to each genotype, and the 5' end and the 3' end are bridge bases.
[0017] Each universal signal probe is 10-30 bases long, and the 5' end is labeled with one of the fluorescent groups of FAM, HEX, JOE, ROX, VIC, Cy3, Cy5, Texas Red, or TAMRA.
[0018] Furthermore, each universal quenching probe is 10-30 bases long, and the 5' end is labeled with any one of MGB, BHQ1, BHQ2, BHQ3, and Dabcyl, a modification group that can quench the fluorescent signal labeled by the signal probe.
[0019] Preferably, the 5' end of the specific amplification primer is 10-30 bases, the probe sequence region of the primer is completely or partially identical to the signal probe or quencher probe base sequence, the 3' end of the specific amplification primer is 10-30 bases that can specifically amplify the target sequence, and there are 0-10 random sequence bridging bases between the 5' end and the 3' end.
[0020] A multi-genotyping detection method comprises using the multi-genotyping detection composition described above.
[0021] A multi-genotyping detection composition is used in a PCR reaction system.
[0022] Wherein, in each reaction system, the concentration of the universal signal probe and the universal quenching probe is 4nM-5μM, and the concentration of the specific amplification primer is 2nM-5μM.
[0023] Furthermore, each reaction system includes Taq DNA polymerase and dNTPs as well as sample DNA containing mutant or wild-type genes, cDNA obtained by reverse transcription, synthesized plasmid DNA, and single-stranded DNA.
[0024] In addition, the present invention also discloses a genotype analysis method, which specifically comprises: completing specific primer amplification and a combination of a universal quenching probe and a universal signal probe through a PCR amplification stage, performing a melting curve detection after the amplification reaction is completed, and analyzing the Tm value and signal channel of the melting curve to determine the genotype and mutation status of the sample to be tested.
[0025] Compared with the prior art, the present invention has the following beneficial effects:
[0026] The present invention adopts a universal probe and specific amplification primer detection system, does not need to specially design Taq Man hydrolysis probes or molecular beacons, and reduces the technical development difficulty of genotyping detection; the universal probe system described in the present invention is compatible with multi-color fluorescence detection, and utilizes the difference in fluorescence channels and the difference in Tm values of amplification product melting curves to achieve more multiple gene detection in a single reaction, thereby improving the efficiency of genotyping and mutation detection; the present invention adopts PCR amplification combined with melting curves for result analysis, which maximizes the sensitivity of detection and analysis, and expands the detection range to genotyping detection, safe drug use detection, tumor mutation detection, pathogenic microorganism resistance monitoring and other aspects. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for use in the embodiments will be briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without paying creative work.
[0028] Figure 1 This is a schematic diagram of the technical principle of multi-genotyping detection in the present invention.
[0029] Figure 2 This is a graph showing the CYP2C19 genotyping test results of the present invention (sample No. 1).
[0030] Figure 3 This is a graph showing the CYP2C19 genotyping test results of the present invention (sample No. 2).
[0031] Figure 4 This is a graph showing the CYP2C19 genotyping test results of the present invention (sample No. 3).
[0032] Figure 5 This is a graph showing the CYP2C19 genotyping test results of the present invention (sample No. 4).
[0033] Figure 6 This is a diagram of the BRCA1 genotyping test results of the present invention (sample No. 1).
[0034] Figure 7 This is a diagram of the BRCA2 genotyping test results of the present invention (sample No. 1).
[0035] Figure 8 This is a diagram of the BRCA1 genotyping test results of the present invention (sample No. 2).
[0036] Fig. 9 This is a diagram of the BRCA2 genotyping test results of the present invention (sample No. 2).
[0037] Fig.10 This is a diagram of the BRCA1 genotyping test results of the present invention (sample No. 3).
[0038] Fig.11 This is a diagram of the BRCA2 genotyping test results of the present invention (sample No. 3).
[0039] Fig.12 This is a diagram of the BRCA1 genotyping test results of the present invention (sample No. 4).
[0040] Fig.13 This is a diagram of the BRCA2 genotyping test results of the present invention (sample No. 4).
[0041] Fig.14 This is a diagram of the BRCA1 genotyping test results of the present invention (sample No. 5).
[0042] Fig.15 This is a diagram of the BRCA2 genotyping test results of the present invention (sample No. 5). DETAILED DESCRIPTION
[0043] In the following, only some exemplary embodiments are briefly described. As those skilled in the art will appreciate, the described embodiments may be modified in various ways without departing from the spirit or scope of the embodiments of the present invention. Therefore, the drawings and descriptions are considered to be exemplary and non-restrictive in nature. Embodiments of the present invention are described in detail below in conjunction with the accompanying drawings.
[0044] The present invention discloses an application of a multi-genotyping detection composition, specifically, applying the multi-genotyping detection composition to a PCR reaction system.
[0045] The multi-genotyping detection composition comprises a universal quenching probe, a plurality of specific amplification primers and a plurality of universal signal probes.
[0046] in,
[0047] The universal quenching probe is an oligonucleotide chain that does not pair with the gene sequence of any known species to undergo an amplification reaction;
[0048] The 5' end of the universal signal probe is respectively labeled with different fluorescent signal groups, and the fluorescent signal of each fluorescent signal group can be quenched by the quenching group of the quenching probe;
[0049] The 5' end of the universal quenching probe is labeled with any one of MGB, BHQ1, BHQ2, BHQ3, and Dabcyl, a modification group that can quench the fluorescent signal labeled by the signal probe;
[0050] The specific amplification primers include specific amplification primer upstream primers and specific amplification primer downstream primers. The specific amplification primer upstream primers are composed of three oligonucleotide sequence structures, the 5' end is a probe sequence region, the 3' end is an amplification sequence region specific to each genotype, and a bridging base is between the 5' end and the 3' end; the specific amplification primer downstream primers are composed of three oligonucleotide sequence structures, the 5' end is a probe sequence, the 3' end is an amplification downstream primer specific to each genotype, and a bridging base is between the 5' end and the 3' end.
[0051] Each universal signal probe is 10-30 bases long, and the 5' end is labeled with one of the fluorescent groups of FAM, HEX, JOE, ROX, VIC, Cy3, Cy5, Texas Red, or TAMRA.
[0052] Furthermore, each universal quenching probe is 10-30 bases long, and the 5' end is labeled with any one of MGB, BHQ1, BHQ2, BHQ3, and Dabcyl, a modification group that can quench the fluorescent signal labeled by the signal probe.
[0053] Preferably, the 5' end of the specific amplification primer is 10-30 bases, the probe sequence region of the primer is completely or partially identical to the signal probe or quencher probe base sequence, the 3' end of the specific amplification primer is 10-30 bases that can specifically amplify the target sequence, and there are 0-10 random sequence bridging bases between the 5' end and the 3' end.
[0054] The present invention also discloses a multi-genotyping detection method, which comprises using the multi-genotyping detection composition described above.
[0055] A multi-genotyping detection composition is used in a PCR reaction system.
[0056] Wherein, in each reaction system, the concentration of the universal signal probe and the universal quenching probe is 4nM-5μM, and the concentration of the specific amplification primer is 2nM-5μM.
[0057] Furthermore, each reaction system includes Taq DNA polymerase and dNTPs as well as sample DNA containing mutant or wild-type genes, cDNA obtained by reverse transcription, synthesized plasmid DNA, and single-stranded DNA.
[0058] The present invention also discloses a genotype analysis method, which specifically comprises: completing specific primer amplification and a combination of a universal quenching probe and a universal signal probe through a PCR amplification stage, performing a melting curve detection after the amplification reaction is completed, and analyzing the Tm value and signal channel of the melting curve to determine the genotype and mutation status of the sample to be tested.
[0059] In order to facilitate those skilled in the art to further understand the present application, the present application is further described below in conjunction with specific implementation cases.
[0060] Embodiment 1
[0061] 1. Template preparation:
[0062] DNA was extracted from four human oral epithelial cell samples.
[0063] The human reference genome GRCh38 sequence was selected to design common PCR amplification primers for three genotypes of CYP2C19*2 / *3 / *17. The nucleic acid template was amplified using a common PCR instrument. After completion, the PCR products were sent to a sequencing company for Sanger sequencing.
[0064] In addition, four human oral epithelial cell DNA samples from the same source were tested using the detection method of the present invention, and finally the results of the two methodologies were compared.
[0065] 2. Primer design:
[0066] According to the universal probes listed in Table 1, the detection signals were distributed.
[0067] Use SEQ ID NO.01 GP1FAM-labeled universal probe to detect CYP2C19*1 genotype, use SEQ ID NO.02 GP2 HEX-labeled universal probe to detect CYP2C19*2 G→A / *3 G→A genotype, use SEQ ID NO.03 GP3 ROX-labeled universal probe to detect CYP2C19*2G→C / CYP2C19*17 C→T genotype, and use SEQ ID NO.04 GP4 Cy5-labeled universal probe to detect CYP2C19*2 G→T genotype.
[0068] Table 1: Universal probe sequences used in the assay
[0069]
[0070] The human reference genome sequence was selected to design three genotype-specific amplification primers for CYP2C19*2 / *3 / *17.
[0071] Table 2: Specific amplification primers for human CYP2C19*2 / *3 / *17 genotyping detection
[0072]
[0073] 3. Preparation of genotyping amplification detection reaction solution
[0074] Complete the preparation of the amplification reaction solution components according to Table 3, and then dispense 15 μL of the PCR reaction solution into each PCR reaction tube.
[0075] Table 3: Reaction system preparation table
[0076]
[0077] 4. Add samples
[0078] Add 10 μL of the extracted sample nucleic acid to the reaction tube containing the PCR reaction solution, cover the tube tightly, and place it in a PCR instrument for amplification. The amplification conditions are shown in Table 5.
[0079] Table 5: Amplification Procedure
[0080]
[0081] 5. Interpretation of results
[0082] In the present invention, if Figure 1 As shown, Figure 1 The figure on the left in the middle shows the reaction principle of PCR amplification of target gene fragments using specific amplification primers + universal probes. Figure 1 The figure on the right side shows the state of the product in the reaction tube after PCR amplification of the target gene fragment with specific primers + universal probe, and the principle of generating the melting curve fluorescence signal.
[0083] The results of this experiment are as follows Figure 2 , Figure 3 , Figure 4 , Figure 5 As shown;
[0084] exist Figure 2 In the results, the Tm value of the FAM fluorescence channel of sample No.1 is 78.32 / 81.56 / 84.78, the Tm value of the CY5 fluorescence channel is 82.53, and there is no melting curve peak in the other fluorescence channels. Referring to the gene information in Table 6, the genotype of sample No.1 is CYP2C19*2.
[0085] exist Figure 3In the results, the Tm value of the FAM fluorescence channel of sample No.2 is 78.32 / 81.56 / 84.78, and the Tm value of the HEX fluorescence channel is 81.76 / 85.01. Referring to the gene information in Table 6, the genotype of sample No.2 is CYP2C19*2 / *3.
[0086] exist Figure 4 In the results, the Tm value of the FAM fluorescence channel of sample No.3 is 78.34 / 81.77 / 84.89, and the Tm value of the ROX fluorescence channel is 81.53 / ROX=84.91. The genotype of sample No.3 is CYP2C19*2 / *17 according to the gene information in Table 6.
[0087] exist Figure 5 In the figure, the Tm value of the FAM fluorescence channel of sample No.4 is 78.55 / 81.68 / 84.90, and the Tm value of the ROX fluorescence channel is 81.78 / =84.88. Referring to the gene information in Table 6, the genotype of sample No.4 is CYP2C19*2 / *17.
[0088] The results were interpreted according to the gene information listed in Table 6 and the results are shown in Table 7.
[0089] Table 6:
[0090]
[0091] Table 7:
[0092]
[0093] According to Table 6 and Table 7, the test results of the test samples in this experiment using the detection method of the present invention are 100% consistent with the first-generation sequencing test results.
[0094] Example 2
[0095] This example provides genotyping detection of BRCA1 and BRCA2.
[0096] 1. Template Preparation
[0097] DNA was extracted from 5 human oral epithelial cell samples. The human reference genome GRCh38 sequence was selected to design common PCR amplification primers for the BRCA1 and BRCA2 genes. The nucleic acid template was amplified using a common PCR instrument. After completion, the PCR products were sent to a sequencing company for Sanger sequencing.
[0098] In addition, 5 human oral epithelial cell DNA samples from the same source were tested using the detection method of the present invention. Finally, the results of the two methodologies were compared.
[0099] 2. Primer Design
[0100] According to the universal probes listed in Table 7, the detection signals were distributed.
[0101] Use SEQ ID NO.01 GP1FAM-labeled universal probe to detect BCRA1 rs80357973 wild-type gene, BRCA1 rs80357772 wild-type gene, BRCA2 rs80358557-C genotype, BRCA2rs398122576 wild-type gene, BRCA2 rs80358474-C genotype;
[0102] Use SEQ ID NO.02 GP2 HEX labeled universal probe to detect BCRA1 rs80357973 mutant gene, BRCA1 rs80357772 mutant gene, BRCA2 rs80358557-A genotype, BRCA2 rs80358474-A genotype;
[0103] SEQ ID NO.03 GP3 ROX marker universal probe was used to detect BRCA2 rs80358557-T genotype and BRCA2 rs80358474-G genotype;
[0104] SEQ ID NO.04 GP4 Cy5-labeled universal probe was used to detect BRCA2 rs398122576 mutant gene and BRCA2 rs80358474-T genotype.
[0105] Table 8: Universal probe sequences used in the assay
[0106]
[0107] The human reference genome sequence was selected to design specific amplification primers for 13 genotypes at five gene loci, BRCA1rs80357973, BRCA1rs80357772, BRCA2rs80358557, BRCA2rs398122576, and BRCA2rs80358474.
[0108] Specific amplification primers for BRCA1, BRCA2, FGFR2, and SIAH2 genotyping detection are shown in Table 9 below;
[0109]
[0110]
[0111]
[0112] 3. Preparation of genotyping amplification detection reaction solution
[0113] According to Table 10, the PCR amplification reaction solution components of reaction tube 1 and reaction tube 2 were prepared respectively. Reaction tube 1 was used to detect the genotype of the BRCA1 gene, and reaction tube 2 was used to detect the genotype of the BRCA2 gene. Then, 15 μL of the PCR reaction solution was dispensed into each PCR reaction tube.
[0114] Table 10: Reaction system preparation table
[0115]
[0116]
[0117] 4. Add samples
[0118] Add 10 μL of the extracted sample nucleic acid to the reaction tube containing the PCR reaction solution, cover the tube tightly, and place it in a PCR instrument for amplification. The amplification conditions are shown in Table 11.
[0119] Table 11: Amplification Procedure
[0120]
[0121] 5. Interpretation of results
[0122] The results of this experiment are as follows Figure 6-Figure 15 As shown,
[0123] exist Figure 6 In the experiment, the Tm value of the FAM fluorescence channel of sample No. 1 in reaction tube 1 is 89.87 / 84.78. Referring to the gene information in Table 12, the BRCA1rs80357973 gene of sample No. 1 is judged to be wild type, and the BRCA1rs80357772 gene is wild type.
[0124] exist Figure 7 In the experiment, the Tm value of FAM fluorescence channel of sample No.1 in reaction tube 2 is 82.01 / 85.17, the Tm value of HEX fluorescence channel is 81.84 / 85.06, and the Tm value of CY5 fluorescence channel is 8.180. Referring to the gene information in Table 12, the genotype of BRCA2rs80358557 of sample No.1 is CA, the genotype of BRCA2rs398122576 is C base deletion, and the genotype of BRCA2rs80358474 is CA.
[0125] exist Figure 8In the reaction tube 1, the Tm value of the FAM fluorescence channel of sample No. 2 is 86.69 / 84.55, and the Tm value of the HEX fluorescence channel is 89.70. Referring to the gene information in Table 12, the BRCA1rs80357973 gene of sample No. 2 is judged to be heterozygous, and the BRCA1rs80357772 gene is wild type.
[0126] exist Fig. 9 In the experiment, the Tm value of FAM fluorescence channel of sample No.2 in reaction tube 2 is 82.01 / 78.74 / 85.17, the Tm value of HEX fluorescence channel is 81.61 / 84.85, and the Tm value of CY5 fluorescence channel is 82.30. Referring to the gene information in Table 12, the genotype of BRCA2rs80358557 of sample No.2 is CA, the genotype of BRCA2rs398122576 is heterozygous, and the genotype of BRCA2rs80358474 is CA.
[0127] exist Fig.10 In the reaction tube 1, the Tm value of the FAM fluorescence channel of sample No. 3 is 89.68 / 84.54, and the Tm value of the HEX fluorescence channel is 89.66 / 84.62. Referring to the gene information in Table 12, it is judged that the BRCA1rs80357973 gene of sample No. 3 is heterozygous, and the BRCA1rs80357772 gene is heterozygous.
[0128] exist Fig.11 In the experiment, the Tm value of FAM fluorescence channel of sample No.3 in reaction tube 2 is 82.01 / 78.74 / 85.17, the Tm value of ROX fluorescence channel is 81.67, and the Tm value of CY5 fluorescence channel is 85.14 / 81.08. Referring to the gene information in Table 12, the genotype of BRCA2rs80358557 of sample No.3 is CT, the genotype of BRCA2rs398122576 is heterozygous, and the genotype of BRCA2rs80358474 is CT.
[0129] exist Fig.12 In the experiment, the Tm value of the FAM fluorescence channel of sample No.4 in reaction tube 1 is 89.57, and the Tm value of the HEX fluorescence channel is 89.70 / 84.60. Referring to the gene information in Table 12, the BRCA1rs80357973 gene of sample No.4 is interpreted as heterozygous, and the BRCA1rs80357772 genotype is AT deletion. Fig.13In the experiment, the Tm value of the FAM fluorescence channel of sample No.4 in reaction tube 2 is FAM=81.68 / 84.90, the Tm value of the ROX fluorescence channel is 81.78, and the Tm value of the CY5 fluorescence channel is 81.80 / 85.14. Referring to the gene information in Table 12, the genotype of BRCA2rs80358557 of sample No.4 is CT, the genotype of BRCA2rs398122576 is C base deletion, and the genotype of BRCA2rs80358474 is CT.
[0130] exist Fig.14 In the experiment, the Tm value of the FAM fluorescence channel of sample No. 5 in reaction tube 1 is 89.68 / 84.54, and the Tm value of the HEX fluorescence channel is 89.70 / 84.60. Referring to the gene information in Table 12, the genotype of BRCA1rs80357973 of sample No. 5 is judged to be heterozygous, and the genotype of BRCA1rs80357772 is heterozygous.
[0131] exist Fig.15 In the experiment, the Tm value of FAM fluorescence channel of sample No.5 in reaction tube 2 is 82.01 / 78.74 / 85.17, the Tm value of ROX fluorescence channel is 81.67 / 84.89, and the Tm value of CY5 fluorescence channel is 82.30. Referring to the gene information in Table 12, the genotype of BRCA2rs80358557 of sample No.5 is CT, the genotype of BRCA2rs398122576 is heterozygous, and the genotype of BRCA2rs80358474 is CG.
[0132] The results were interpreted according to the gene information listed in Table 12 and the result graph. The interpretation results are shown in Table 13. Table 12:
[0133]
[0134]
[0135] Table 13 Sample test results:
[0136]
[0137]
[0138]
[0139] According to Tables 12 and 13, it can be seen that the test results of the test samples in this experiment using the detection method of the present invention are 100% consistent with the first-generation sequencing test results.
[0140] Although the preferred embodiments of the present invention have been described, those skilled in the art may make other changes and modifications to these embodiments once they have learned the basic creative concept. Therefore, the appended claims are intended to be interpreted as including the preferred embodiments and all changes and modifications that fall within the scope of the present invention.
[0141] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. It should be pointed out that any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A multi-genotyping detection composition, characterized in that: The multi-genotyping detection composition comprises a universal quenching probe, a plurality of specific amplification primers and a plurality of universal signal probes. in, The universal quenching probe and the universal signaling probe are oligonucleotide chains that do not pair with the gene sequence of any known species to undergo an amplification reaction; The 5' end of the universal signal probe is respectively labeled with different fluorescent signal groups, and the fluorescent signal of each fluorescent signal group can be quenched by the quenching group of the quenching probe; The 5' end of the universal quenching probe is labeled with any one of MGB, BHQ1, BHQ2, BHQ3, and Dabcyl, a modification group that can quench the fluorescent signal labeled by the signal probe; The specific amplification primers include a specific amplification primer upstream primer and a specific amplification primer downstream primer. The specific amplification primer upstream primer is composed of three oligonucleotide sequence structures, the 5' end is a probe sequence region, the 3' end is an amplification sequence region specific to each genotype, and a bridging base is between the 5' end and the 3' end; The specific amplification primer downstream primers are composed of three oligonucleotide sequence structures, the 5' end is a probe sequence, the 3' end is a genotype-specific amplification downstream primer, and the 5' end and the 3' end are bridge bases; In each reaction system, the concentration of universal signal probe and universal quenching probe is 4nM-5μM, and the concentration of specific amplification primer is 2nM-5μM; The universal signal probe gene sequence is shown in SEQ ID NO.01-SEQ ID NO.04, and the universal quenching probe gene sequence is shown in SEQ ID NO.05; The specific amplification primers are shown in the sequences of SEQ ID NO.06, SEQ ID NO.07 and SEQ ID NO.09-SEQ ID NO.
16.
2. A multi-genotyping detection composition according to claim 1, characterized in that: The 5' end of each universal signal probe is labeled with one of the fluorescent groups including FAM, HEX, JOE, ROX, VIC, Cy3, Cy5, Texas Red, or TAMRA.
Citation Information
Patent Citations
Universal compositions and methods for multiplex genotyping
CN118667923A
